New Key Statistics Module, Z-Score and F-Score
NAS:UTHR Key Ratios
Market Cap $ M | 11,724.73 |
Enterprise Value $ M | 9,616.93 |
P/E(ttm) | 12.50 |
PE Ratio without NRI | 12.50 |
Forward PE Ratio | 11.52 |
Price/Book | 2.19 |
Price/Sales | 5.26 |
Price/Free Cash Flow | 17.46 |
Price/Owner Earnings | 16.04 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 2,498.00 |
EPS (TTM) $ | 21.15 |
Beneish M-Score | -1.39 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 43.40 |
EV-to-EBIT | 6.68 |
EV-to-EBITDA | 6.43 |
PEG | -- |
Shares Outstanding M | 44.37 |
Net Margin (%) | 42.05 |
Operating Margin % | 50.31 |
Pre-tax Margin (%) | 55.28 |
Quick Ratio | 3.64 |
Current Ratio | 3.77 |
ROA % (ttm) | 15.58 |
ROE % (ttm) | 19.05 |
ROIC % (ttm) | 25.35 |
Dividend Yield % | -- |
Altman Z-Score | 9.00 |
UTHR Number of Guru Trades
UTHR Volume of Guru Trades
Gurus Latest Trades with NAS:UTHR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:UTHR is held by these investors
Total 6
United Therapeutics Corp Insider Transactions
No Available Data
News about NAS:UTHR
Total 0- 1